RWLK - ReWalk Robotics Ltd.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
0.6099
+0.0195 (+3.30%)
At close: 04:00PM EDT
0.6300 +0.02 (+3.30%)
After hours: 07:29PM EDT
Stock chart is not supported by your current browser
Previous close0.5904
Open0.6000
Bid0.5900 x 4000
Ask0.6300 x 900
Day's range0.5900 - 0.6099
52-week range0.5600 - 1.1400
Volume117,341
Avg. volume180,387
Market cap36.332M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    ReWalk Robotics Reports First Quarter 2023 Financial Results

    On-Track Start to Fiscal Year with Progress in Advancing Reimbursement Coverage for Medicare Beneficiaries MARLBOROUGH, Mass. BERLIN and YOKNEAM ILLIT, Israel, May 11, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading provider of innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurological conditions, today announced its financial results for the three months ended March 31, 2023. Hi

  • GlobeNewswire

    ReWalk Robotics to Provide First U.S. Demonstrations of Groundbreaking Stairs-Enabled Exoskeleton Technology

    ReWalk Robotics will unveil its innovative new exoskeleton to the public at the upcoming Abilities Expo in New York, with live demonstrations from paralyzed individuals who use the technology to regain ambulatory access to real-world environments, including stairs and curbsMARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 04, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “The Company”), a leading provider of innovative technologies that enable mobility and wellness in

  • GlobeNewswire

    ReWalk Robotics Ltd. to Report First Quarter Financial Results on May 11, 2023

    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, May 03, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that the Company will release its first quarter 2023 financial results before the markets open on Thursday, May 11, 2023. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call and live webcast at 8:30 a.m. EDT to discuss the financial results. To access the call, analysts an

  • GlobeNewswire

    ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on May 10

    Unveils New Investor Presentation on WebsiteMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 03, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced Larry Jasinski, Chief Executive Officer, and Mike Lawless, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, taking place on May 10-11, 2023. The presentation will begin at 9:15 AM EDT on May 10, 2023 and can be ac

  • GlobeNewswire

    Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs

    Paralyzed individuals with spinal cord injury will have unprecedented access to walking in everyday environments as they are no longer limited when encountering stairs and curbs ReWalk Users Now Able to Access Stairs and Curbs in the US A paralyzed individual walks up the stairs to visit a friend's home using her ReWalk Personal Exoskeleton. MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 07, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd., (Nasdaq: RWLK) (“ReWalk” or the “Company”),

  • GlobeNewswire

    ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results

    Strong Conclusion to 2022 – Q4’22 Revenue Highest Since Start of COVID-19 Pandemic Record Quarterly MyoCycle Sales Supplement Improved Exoskeleton Revenue MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 23, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a medical device company that designs, develops, and commercializes innovative technologies that enable mobility and wellness in rehabilitation and daily life for individuals with neurologic

  • GlobeNewswire

    ReWalk Robotics to Report Fourth Quarter and Fiscal Year-End 2022 Financial Results on February 23, 2023

    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 16, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter and fiscal year-end 2022 financial results on Thursday, February 23, 2023, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows: Time8:30 A.M ESTToll free (U.S.

  • GlobeNewswire

    “Modern Miracles”: ReWalk Technology Showcased at the Hanukkah Celebration Hosted by the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp

    ReWalk Robotics, Ltd. is honored to have presented its technology at the prestigious Modern Miracles Celebration with the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp. Her Excellency Idit Rosenzweig Abu, Ambassador of Israel to Belgium, and Mr. Jacques Depuydt Her Excellency Idit Rosenzweig Abu, Ambassador of Israel to Belgium, and Mr. Jacques Depuydt, the first ReWalker in Belgium Her Excellency Idit Rosenzweig Abu, Ambassador of Israel to Belgium, and Mr. Jacques Depuydt

  • GlobeNewswire

    ReWalk Announces Extension of Share Repurchase Program

    Reflects Confidence in Long-Term Potential of ReWalkMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Dec. 22, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors (the “Board”) has approved an extension of the current program to repurchase the Company’s Ordinary Shares, par value NIS 0.25 per share, with such ex

  • GlobeNewswire

    Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation

    Precedent set for all future cases as State Court verdict is legally binding and enforceable Following the outcome of this legal dispute, eligible paraplegics in Germany have an easier pathway to be provided with a ReWalk exoskeleton going forward MARLBOROUGH, Mass. and BERLIN, Nov. 11, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), today welcomed the decision by BARMER to accept the prior ruling from the state court that exoskeletons are considered as

  • GlobeNewswire

    ReWalk Robotics Reports Third Quarter 2022 Financial Results

    ReWalk Has Submitted the First Case to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries As of November 4th, ReWalk Has Repurchased $0.9 Million of Common Stock Since Initiation of Its Program German Federal Social Court Hearing on November 10th with Ruling Expected Shortly After MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Nov. 07, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the

  • GlobeNewswire

    ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022

    MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows: Time8:30 A.M ESTToll free (U.S.)1-833-630-1956Inte

  • GlobeNewswire

    ReWalk Takes Another Step Toward Medicare Coverage

    ReWalk to submit first cases for Medicare coverage through Medicare Administrative Contractors (MACs)Centers for Medicare and Medicaid Services (CMS) affirms that the MACs have discretion to cover and reimburse the ReWalk exoskeletonCMS also plans to further deliberate on a benefit category designation for the ReWalk exoskeleton and has said that it will provide more information in the near future MARLBOROUGH, Mass., Sept. 28, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk

  • GlobeNewswire

    German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals

    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 12, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the German Federal Social Court has scheduled a hearing to review the decision of whether an exoskeleton medical device should be classified as directly or indirectly compensating for the lost function of individuals with spinal

  • GlobeNewswire

    ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer

    Brings Significant Experience in M&A, Investor Relations, and Financial StrategyMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the appointment of Michael Lawless, CPA, as Chief Financial Officer, effective September 19, 2022. Mr. Lawless brings more than 20 years of experienc

  • GlobeNewswire

    ReWalk Robotics Reports Second Quarter 2022 Financial Results

    Highlights June 8th Milestone Participation at Biannual CMS HCPCS Public Meeting as Part of Efforts to Gain “Artificial Legs” Benefit Category Classification as Prosthetic for ReWalk Device Has Submitted 510k Application for ReWalk Stairs and Curbs Functionality MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and six months ended June 30, 2

  • GlobeNewswire

    ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 03, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022, at 8:30 AM Eastern time. Larry Jasinski, Chief Executive Officer, and Almog Adar, Director of Finance, will host a conference call to discuss the results as follows: Time8:30 A.M EDTToll free (U.S.)(866) 374-5140International (U.S

  • GlobeNewswire

    ReWalk Robotics Announces Results of 2022 Annual Meeting

    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Aug. 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's 2022 Annual Meeting of Shareholders (the “Annual Meeting”) based on the final tabulation of votes certified by an independent Inspector of Elections. At the Annual Meeting, shareholders voted to reelec

  • GlobeNewswire

    ReWalk Receives Court Approval for Share Repurchase Program

    MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli court approval to repurchase up to $8 million of its Ordinary Shares, par value NIS 0.25 per share. The court approval is valid through January 20, 2023. Under the program, share repurchases may be mad

  • GlobeNewswire

    100th ReWalk Exoskeleton Supplied in Germany

    21-year-old Lukas Gloßner from Nürnberg is the 100th paraplegic in Germany to be provided with a ReWalk Personal ExoskeletonBERLIN, June 23, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd (Nasdaq: RWLK) ("ReWalk" or "the Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, announces the 100th placement of an exoskeleton in Germany. The first official reimbursement for a ReWalk exoskeleton supply was by the German statutory accident insuranc

  • Business Wire

    ReWalk Provides Notice of 2022 Annual Meeting of Shareholders

    MARLBOROUGH, Mass. & BERLIN & YOKNEAM ILIT, Israel, June 10, 2022--ReWalk Robotics Ltd. (Nasdaq: RWLK), (the "Company" or "ReWalk"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today provided notice that the 2022 Annual Meeting of Shareholders (the "Meeting") will be held on Wednesday, July 27, 2022, at 10:00 a.m. EDT at the Hyatt Place Marlborough / Apex Center Hotel in Marlborough, Massachusetts.

  • GlobeNewswire

    ReWalk Robotics Announces Share Repurchase Program

    MARLBOROUGH, Mass. BERLIN and YOKNEAM ILIT, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors (the “Board”) has approved a program to repurchase up to $8 million of its Ordinary Shares, par value NIS 0.25 per share. The program is subject to receipt of court approval, and ReWalk has filed a motion r